211 related articles for article (PubMed ID: 7675765)
41. Selective mutation of codons 204 and 213 of the p53 gene in rat tumors induced by alkylating N-nitroso compounds.
Ohgaki H; Hard GC; Hirota N; Maekawa A; Takahashi M; Kleihues P
Cancer Res; 1992 May; 52(10):2995-8. PubMed ID: 1316233
[TBL] [Abstract][Full Text] [Related]
42. Identification of mutations in the WT1 gene in tumours from patients with the WAGR syndrome.
Baird PN; Groves N; Haber DA; Housman DE; Cowell JK
Oncogene; 1992 Nov; 7(11):2141-9. PubMed ID: 1331933
[TBL] [Abstract][Full Text] [Related]
43. Multiplex PCR-SSCP for simultaneous screening for mutations in several exons of p53.
Ozçelik H; Andrulis IL
Biotechniques; 1995 May; 18(5):742-4. PubMed ID: 7619467
[No Abstract] [Full Text] [Related]
44. [Four new cases with WT1 gene mutations in Chinese patients with Wilms' tumor].
Jiang YP; Shen Y; Sun N; Wang H
Zhonghua Er Ke Za Zhi; 2009 Oct; 47(10):762-6. PubMed ID: 20021811
[TBL] [Abstract][Full Text] [Related]
45. Identification and analysis of mutations in WTX and WT1 genes in peripheral blood and tumor tissue of children with Wilms' tumor.
Wang H; Shen Y; Sun N; Jiang YP; Li ML; Sun L
Chin Med J (Engl); 2012 May; 125(10):1733-9. PubMed ID: 22800892
[TBL] [Abstract][Full Text] [Related]
46. [Characterization of mutation of the P53 gene in lymphomas].
Martínez-Delgado B; Robledo M; Arranz E; Rivas C; Benítez J
Sangre (Barc); 1995 Aug; 40(4):301-5. PubMed ID: 7482119
[TBL] [Abstract][Full Text] [Related]
47. Aberrant expression of the tumour suppressor gene p53 is very frequent in Wilms' tumours.
Lemoine NR; Hughes CM; Cowell JK
J Pathol; 1992 Oct; 168(2):237-42. PubMed ID: 1334142
[TBL] [Abstract][Full Text] [Related]
48. The pattern of p53 mutations in Burkitt's lymphoma differs from that of solid tumors.
Bhatia KG; Gutiérrez MI; Huppi K; Siwarski D; Magrath IT
Cancer Res; 1992 Aug; 52(15):4273-6. PubMed ID: 1638540
[TBL] [Abstract][Full Text] [Related]
49. Low frequency of mutations in the WT1 coding region in Wilms' tumor.
Brown KW; Wilmore HP; Watson JE; Mott MG; Berry PJ; Maitland NJ
Genes Chromosomes Cancer; 1993 Oct; 8(2):74-9. PubMed ID: 7504520
[TBL] [Abstract][Full Text] [Related]
50. Loss of heterozygosity for chromosome region 11p15 in Wilms' tumours is not related to HRAS gene transforming mutations.
Baird P; Wadey R; Cowell J
Oncogene; 1991 Jul; 6(7):1147-9. PubMed ID: 1861864
[TBL] [Abstract][Full Text] [Related]
51. A novel p53 mutation hotspot at codon 132 (AAG-->AGG) in human renal cancer.
Dahiya R; Deng G; Selph C; Carroll P; Presti J
Biochem Mol Biol Int; 1998 Feb; 44(2):407-15. PubMed ID: 9530523
[TBL] [Abstract][Full Text] [Related]
52. Association of Wilms' tumor with primary brain tumor in siblings.
Rainov NG; Lübbe J; Renshaw J; Pritchard-Jones K; Lüthy AR; Aguzzi A
J Neuropathol Exp Neurol; 1995 Mar; 54(2):214-23. PubMed ID: 7876889
[TBL] [Abstract][Full Text] [Related]
53. Anaplastic Wilms' tumour, a subtype displaying poor prognosis, harbours p53 gene mutations.
Bardeesy N; Falkoff D; Petruzzi MJ; Nowak N; Zabel B; Adam M; Aguiar MC; Grundy P; Shows T; Pelletier J
Nat Genet; 1994 May; 7(1):91-7. PubMed ID: 8075648
[TBL] [Abstract][Full Text] [Related]
54. Hotspot mutations of BRAF gene are not associated with pediatric solid neoplasms.
Miao J; Kusafuka T; Fukuzawa M
Oncol Rep; 2004 Dec; 12(6):1269-72. PubMed ID: 15547749
[TBL] [Abstract][Full Text] [Related]
55. Heterogeneity in p53 mutations in mouse mammary tumor subpopulations with different metastatic potential from the orthotopic site.
Shekhar PV; Werdell J; Christman JK; Miller FR
Anticancer Res; 1995; 15(3):815-20. PubMed ID: 7645964
[TBL] [Abstract][Full Text] [Related]
56. Immunohistochemical expression of p53 proteins in Wilms' tumour: a possible association with the histological prognostic parameter of anaplasia.
Cheah PL; Looi LM; Chan LL
Histopathology; 1996 Jan; 28(1):49-54. PubMed ID: 8838120
[TBL] [Abstract][Full Text] [Related]
57. Bilateral wilms tumor with TP53-related anaplasia.
Popov SD; Vujanic GM; Sebire NJ; Chagtai T; Williams R; Vaidya S; Pritchard-Jones K
Pediatr Dev Pathol; 2013; 16(3):217-23. PubMed ID: 23387809
[TBL] [Abstract][Full Text] [Related]
58. Infrequency of ras, p53, WT1, or RB gene alterations in Wilms tumors.
Waber PG; Chen J; Nisen PD
Cancer; 1993 Dec; 72(12):3732-8. PubMed ID: 8252491
[TBL] [Abstract][Full Text] [Related]
59. Splicing of exon 5 in the WT1 gene is disrupted in Wilms' tumour.
Simms LA; Algar EM; Smith PJ
Eur J Cancer; 1995 Dec; 31A(13-14):2270-6. PubMed ID: 8652255
[TBL] [Abstract][Full Text] [Related]
60. Lessons from Wilms' tumor.
Quah TC; Lam SK
J Singapore Paediatr Soc; 1992; 34(1-2):99-105. PubMed ID: 1338917
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
